Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Am J Physiol Heart Circ Physiol. 2021 May 1;320(5):H1935-H1948. doi: 10.1152/ajpheart.00061.2021. Epub 2021 Apr 2.
Brugada syndrome (BrS) is a rare, inherited arrhythmia with high risk of sudden cardiac death. To evaluate the molecular convergence of clinically relevant mutations and to identify developmental cardiac cell types that are associated with BrS etiology, we collected 733 mutations represented by 16 sodium, calcium, potassium channels, and regulatory and structural genes related to BrS. Among the clinically relevant mutations, 266 are unique singletons and 88 mutations are recurrent. We observed an over-representation of clinically relevant mutations (∼80%) in gene and also identified several candidate genes, including , , and . Furthermore, protein domain enrichment analysis revealed that a large proportion of the mutations impacted ion transport domains in multiple genes, including , , and A comparative protein domain analysis of further established a significant ( = 0.04) enrichment of clinically relevant mutations within ion transport domain, including a significant ( = 0.02) mutation hotspot within 1321-1380 residue. The enrichment of clinically relevant mutations within ion transport domain is stronger ( = 0.00003) among early onset of BrS. Our spatiotemporal cellular heart developmental (prenatal to adult) trajectory analysis applying single-cell transcriptome identified the most frequently BrS-mutated genes ( and ) are significantly upregulated in the prenatal cardiomyocytes. A more restrictive cellular expression trajectory is prominent in the adult heart ventricular cardiomyocytes compared to prenatal. Our study suggests that genomic and proteomic hotspots in BrS converge into ion transport pathway and cardiomyocyte as a major BrS-associated cell type that provides insight into the complex genetic etiology of BrS. Brugada syndrome is a rare inherited arrhythmia with high risk of sudden cardiac death. We present the findings for a molecular convergence of clinically relevant mutations and identification of a single-cell transcriptome-derived cardiac cell types that are associated with the etiology of BrS. Our study suggests that genomic and proteomic hotspots in BrS converge into ion transport pathway and cardiomyocyte as a major BrS-associated cell type that provides insight into the complex genetic etiology of BrS.
布鲁加达综合征(BrS)是一种罕见的遗传性心律失常,有发生心源性猝死的高风险。为了评估临床相关突变的分子趋同,并确定与 BrS 病因相关的发育性心脏细胞类型,我们收集了 733 个突变,这些突变代表了与 BrS 相关的 16 个钠、钙、钾通道以及调节和结构基因。在临床相关突变中,266 个是独特的单体,88 个是重复突变。我们观察到在 基因中临床相关突变(约 80%)的过度表达,并且还确定了几个候选基因,包括 、 、 。此外,蛋白质结构域富集分析显示,很大一部分突变影响了多个基因的离子转运结构域,包括 、 、 。对 的比较蛋白质结构域分析进一步证实了离子转运结构域中临床相关突变的显著富集(=0.04),包括 1321-1380 残基内的显著突变热点(=0.02)。在 BrS 早期发病中,离子转运结构域内的临床相关突变富集更强(=0.00003)。我们应用单细胞转录组学的时空心脏发育(从产前到成年)轨迹分析发现,最常发生 BrS 突变的基因( 和 )在产前心肌细胞中显著上调。与产前相比,成年人心室心肌细胞中表现出更为局限的细胞表达轨迹。我们的研究表明,BrS 的基因组和蛋白质组热点汇集到离子转运途径和心肌细胞中,作为主要的 BrS 相关细胞类型,为 BrS 的复杂遗传病因提供了深入了解。